Dorman Products (DORM) Cash & Equivalents (2010 - 2026)

Dorman Products' Cash & Equivalents history runs 17 years deep, the most recent figure standing at $43.1 million for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 28.96% year-over-year to $43.1 million; the TTM figure through Mar 2026 stood at $43.1 million (down 28.96% YoY), while the FY2025 annual figure was $49.4 million, down 13.48% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $43.1 million, down from $49.4 million in the prior quarter.
• The five-year high for Cash & Equivalents was $60.6 million in Q1 2025, with the low at $32.0 million in Q3 2023.
• The 5-year median for Cash & Equivalents is $46.0 million (2022), against an average of $45.5 million.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents sank 67.93% in 2022, then jumped 76.03% in 2025.
• Dorman Products' Cash & Equivalents stood at $46.0 million in 2022, then decreased by 20.03% to $36.8 million in 2023, then jumped by 55.2% to $57.1 million in 2024, then slipped by 13.48% to $49.4 million in 2025, then dropped by 12.91% to $43.1 million in 2026.
• Business Quant data shows DORM's Cash & Equivalents at $43.1 million in Q1 2026, $49.4 million in Q4 2025, and $55.5 million in Q3 2025.